Need pharma insights? Register for Evaluate Discovery
Menu
Menu
Tracking potential partners, acquisitions, and competitors helps you seize opportunities and manage portfolio risk. But company profiling can be complex and daunting. As your team sifts through multiple datasets, how do you find timely insights and avoid bias
Identify, profile, and monitor the right companies for your growth strategy. Easily track financials, pipeline developments, M&A activity, and more. Validate potential investments with confidence and strategically prioritise your portfolio for the highest return.
Understand the importance of what’s happening in the landscape and what it means for your portfolio. Identify the right companies to profile based on the attributes that matter most to your strategy. Learn about each company’s financial performance and future critical events.
Once you have a shortlist of promising targets, identify which are looking for partnerships. Create and manage target lists and use our accurate and reliable data to track and analyse how their assets compare to competitors by phase.
Use powerful tools, data, and analysis to identify opportunities and manage your portfolio risk. Our externally audited methodology provides unbiased company updates, helping you refine your profiling process, align with your goals, and optimise ROI.
Make informed decisions on acquisition and partnership strategies by assessing companies based on their financial and portfolio health, comparing them against each other, and utilising tools such as Company Screening, Risk and Return Landscapes, and EVP Analysis.
Gain insights into the future potential of assets, including predicted sales, success rates, and timelines, while also understanding the current and future financial and portfolio health of companies.
Know which opportunities and markets offer the highest growth potential. Focus your resources strategically.
Find and validate pharma opportunities with a robust assessment of market fit, risk, uptake and sales forecasts, and more.
Know which opportunities and markets offer the highest growth potential. Focus your resources strategically.
Build a better understanding of your growth drivers and product differentiators with a clear analysis of market dynamics, trends, unmet needs, and competitors.
Determine the true worth and potential of assets, score high-value opportunities, and make confident licensing or acquisition decisions.
Triangulate internal assumptions and power your allocation strategy with external benchmarking data across the R&D landscape.
Understand the context with data-driven insights
Kelly Chamberlain may not have been at the company very long, but that didn’t stop me swooping in to find out a little more about her. Kelly has joined Norstella,...
If you missed our recent webinar, AI and ML in Pharma: Redefining the Forecasting Landscape, then I hope it’s because you were on a lovely vacation somewhere. Now that you’re...
There is no shortage of discussion about the opportunities presented by artificial intelligence and AI in the pharma industry. 50% of global healthcare companies plan to implement AI strategies by...
Evaluate’s annual World Preview report is a must-read for many in the pharma industry. Each year, we pull together some of our key pharma forecasts to build a picture of...
Can Forecasting Help Identify Market Opportunities for Pharmaceutical Companies? Forecasting serves to help pharmaceutical companies identify market opportunities, particularly when taking a sales-based approach and considering the wider competitive set....
Many pharmaceutical companies are harnessing digital solutions to elevate global forecasting. Digital tools, such as cloud-based, SaaS environments, are powering efficient, streamlined, and intelligent forecasting processes. But, for technological solutions...
